| Value | ₹1.20 Cr |
|---|
BSE filing, NSE: DMART. Summary written from the filing by ALFA Finder's alert engine.
Avenue Supermarts Ltd: key numbers
- Share price
- ₹3,133.90
- Market cap
- ₹2,04,427 Cr
- Revenue (annual)
- ₹68,821 Cr
- Net profit (annual)
- ₹2,970 Cr
- P/E (TTM)
- 65.6×Sector 61.5×
- Promoter holding
- 74.48%+0.00% QoQ
- FII holding
- 8.48%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Avenue Supermarts Ltd
All →Avenue Supermarts Other Announcement
Avenue Supermarts disclosed PIT Reg 7(2) trades by designated persons, mainly pledge invocations to repay ESOP loans. Aggregate disclosed value is about Rs 2.24 Crore.
- Value
- ₹2.24 Cr
Avenue Supermarts Legal & Regulatory
Avenue Supermarts was penalised Rs.55.75 lakhs by GIFT City authority for project completion delays. The company is evaluating the penalty letter and says operations are unaffected.
- Value
- ₹0.56 Cr
Avenue Supermarts Other Announcement
Avenue Supermarts disclosed two designated persons' pledge invocations to repay ESOP exercise loans. Shares disposed on 22 October 2026 were worth a combined Rs.1.89 Crore.
- Value
- ₹1.89 Cr
Avenue Supermarts Other Announcement
Avenue Supermarts disclosed insider trading filings involving designated persons. These disclosures detail recent market sales and pledge invocations of equity shares.
- Value
- ₹0.46 Cr
Avenue Supermarts Other Announcement
Designated persons of Avenue Supermarts Ltd disclosed transactions involving pledge creation and invocation for equity shares, totaling ₹5.29 Crore in value.
- Value
- ₹5.29 Cr
Avenue Supermarts Promoter Reclassification
Avenue Supermarts announced the reclassification of Mr. Vijay Shankar Chandak from the Promoter Group to the Public category, following receipt of exchange no-objection certificates.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.